10x Genomics, Inc. (TXG)

NMS – Real Time Price. Currency in USD

57.36

-1.12 (-1.92%)

Market open: Aug 12, 2026, 3:47 PM EDT

58.47

-0.01 (-0.02%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

643M

611M

619M

516M

Cost of goods sold

-190M

-183M

-209M

-120M

Gross Profit

452M

428M

409M

396M

Operating expenses (excl. COGS)

-553M

-620M

-611M

-560M

Operating Income

-100M

-192M

-202M

-164M

Non-operating income, total

60M

14M

-47M

Pretax income

-40M

-178M

-249M

-162M

Equity in earnings

Taxes

-4M

-5M

-6M

-4M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-44M

-183M

-255M

-166M

Discontinued operations

Net income

-44M

-183M

-255M

-166M

Dilution adjustment

Preferred dividends

10x Genomics, Inc. (TXG)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

10x Genomics, Inc. (TXG)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

10x Genomics, Inc. (TXG)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

10x Genomics, Inc. (TXG)

Income Statement (Annual)

Income Statement (Annual)